JPRN-UMIN000003095已完成3 期
Evaluation of HLA-B*5701 screening prior to abacavir administration for prevention of the hypersensitivity reaction. - HLA-B*5701 screening for prevention of abacavir hypersensitivity reaction.
Department of Pharmacy, University of Fukui Hospital0 个研究点目标入组 10 人开始时间: 2010年2月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients received abacavir once, or with severe hepatic dysfunction.
研究者
相似试验
已完成
4 期
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityHIV InfectionNCT00340080GlaxoSmithKline1,806
已完成
不适用
Evaluation of screening for hepatitis B and C virus infection as part of the general health examination in primary care practices (GesuHep)B15-B19Viral hepatitisDRKS00031077Medizinische Hochschule Hannover337
进行中（未招募）
1 期
Ancillary study on a sub-population of the chronic hepatitis B patients enrolled in the TH HBV VV-001 study to investigate the potential shedding of ChAd155-hIi-HBV after intramuscular administratioEUCTR2017-002574-39-DEGlaxoSmithKline Biologicals76
尚未招募
Unknown
Anti-HBs Antibody Titres among healthcare workers vaccinated against Hepatitis B in AIIMS RajkotCTRI/2024/07/070546All India Institute Of Medical Sciences Rajkot
已完成
不适用
An Open-Label, Single-arm, Phase I study of AEB071 (a Protein Kinase C Inhibitor) in Patients with CD79-mutant Diffuse Large B-Cell LymphomaDiffuse Large B Cell Lymphomanon-hodgkin lympohma10025320NL-OMON38217ovartis6